FOLH1 and prostate cancer: With the advance of molecular biology research, new imaging agents such as 11C-choline and 68Ga-prostate-specific membrane antigen were reported to be more accurate in the diagnosis and recurrence evaluation of prostate cancer than 18F-FDG [16].